I completed my PhD in 2011 at the School of Chemistry, National University of Ireland Galway. My PhD involved the synthesis and biological evaluation of novel imidazo-benzimidazole quinone anti-cancer compounds.
Following my PhD I spent two years working as a Postdoctoral Research Fellow at the School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia. I designed and synthesized a library of synthetic lipopeptide based self-adjuvanting vaccine candidates against Group A Streptococcus.
In 2014 I returned to Ireland where I took up employment as a Technical Development Chemist, GlaxoSmithKline (Currabinny, Cork, Ireland). I provided technical chemical expertise relating to the production of a range of active pharmaceutical ingredients.
In March 2016 I commenced my current role as Postdoctoral Scientist – Medicinal Chemistry, to design and synthesize small molecule inhibitors of epigenetic targets as part of ongoing epigenetic target validation studies by the Structural Genomics Consortium (SGC)-Oxford.